Stay updated on Azacitidine, Venetoclax, Gilteritinib Clinical Trial
Sign up to get notified when there's something new on the Azacitidine, Venetoclax, Gilteritinib Clinical Trial page.

Latest updates to the Azacitidine, Venetoclax, Gilteritinib Clinical Trial page
- CheckyesterdayChange DetectedThe record history now shows a new revision tag (v3.4.3) and the previous tag (v3.4.2) is removed.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and an older government funding notice was removed.SummaryDifference0.6%

- Check37 days agoChange DetectedThe page now shows a site-wide funding notice and adds version v3.4.1 in the record history, while removing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check44 days agoChange DetectedUI changes include adding a Show glossary option, visual color-coding explanations for changes, and new/updated revision labels on the history page, while footer notes such as No FEAR Act data were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check58 days agoChange DetectedA new version entry (v3.3.4) was added and a previous entry (v3.3.3) was removed from the study record history, which are metadata updates to the history table rather than substantive changes to the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer, indicating minor version housekeeping. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Azacitidine, Venetoclax, Gilteritinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine, Venetoclax, Gilteritinib Clinical Trial page.